Literature DB >> 8757957

Differential expression of CD22 (Lyb8) on murine B cells.

L D Erickson1, L T Tygrett, S K Bhatia, K H Grabstein, T J Waldschmidt.   

Abstract

Previous studies have established the distribution, biochemistry and functional attributes of human CD22, a B cell-restricted glycoprotein. Recently, molecular cloning of the murine CD22 equivalent revealed this molecule to be the same as the previously described Lyb8 alloantigen. Using the anti-Lyb8 mAb Cy34.1.2, the present report documents the expression patterns of CD22 within the murine B cell compartment. The results demonstrate that in the bone marrow, murine CD22 is absent on the surface of pro-B cells, pre-B cells and newly emerging IgM+ B cells. CD22 is present at a low density on immature IgMhi B cells and fully expressed on mature recirculating B cells. In the periphery, murine CD22 is expressed at mature levels on all B cell subsets including follicular, marginal zone, B1 and switched B cells. Further studies showed CD22 to be retained on activated murine B cells for extended periods. Finally, in combination with CD23 and heat stable antigen, CD22 can be used to delineate the immature splenic B cells, and distinguish them from follicular and marginal zone cells. Together, the results demonstrate murine CD22 to be a useful pan marker for all mature B cell subsets.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757957      PMCID: PMC2859887          DOI: 10.1093/intimm/8.7.1121

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  45 in total

1.  Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells.

Authors:  D M Allman; S E Ferguson; V M Lentz; M P Cancro
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

2.  Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells.

Authors:  M F Bachmann; T M Kündig; B Odermatt; H Hengartner; R M Zinkernagel
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

3.  Lyb-8.2: A new B cell antigen defined and characterized with a monoclonal antibody.

Authors:  F W Symington; B Subbarao; D E Mosier; J Sprent
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

4.  Organization of the murine Cd22 locus. Mapping to chromosome 7 and characterization of two alleles.

Authors:  C L Law; R M Torres; H A Sundberg; R M Parkhouse; C I Brannan; N G Copeland; N A Jenkins; E A Clark
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

Review 5.  Regulation of lymphocyte activation by the cell-surface molecule CD22.

Authors:  C L Law; S P Sidorenko; E A Clark
Journal:  Immunol Today       Date:  1994-09

6.  A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP.

Authors:  G M Doody; L B Justement; C C Delibrias; R J Matthews; J Lin; M L Thomas; D T Fearon
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

7.  Antibody response of murine B1 cells to hen eggwhite lysozyme.

Authors:  L A Vogel; E E Sercarz; D W Metzger
Journal:  Cell Immunol       Date:  1995-03       Impact factor: 4.868

8.  Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.

Authors:  P Engel; N Wagner; A S Miller; T F Tedder
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

9.  Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice.

Authors:  J F Kearney; M D Cooper; J Klein; E R Abney; R M Parkhouse; A R Lawton
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

10.  B-lymphocyte heterogeneity: ontogenetic development and organ distribution of B-lymphocyte populations defined by their density of surface immunoglobulin.

Authors:  I Scher; S O Sharrow; R Wistar; R Asofsky; W E Paul
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Characterization of splenic CD21hi T2 B cells.

Authors:  Shilpi Verma; Thomas J Waldschmidt
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Murine B1 B cells require IL-5 for optimal T cell-dependent activation.

Authors:  L D Erickson; T M Foy; T J Waldschmidt
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

3.  Immunodeficiency due to a unique protracted developmental delay in the B-cell lineage.

Authors:  A S Goldman; S E Miles; H E Rudloff; K H Palkowetz; F C Schmalstieg
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

4.  Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance.

Authors:  Andrew J Gross; Julia R Lyandres; Anil K Panigrahi; Eline T Luning Prak; Anthony L DeFranco
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

5.  Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells.

Authors:  R J Benschop; D Melamed; D Nemazee; J C Cambier
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

6.  Profiling the Atlantic Salmon IgM+ B Cell Surface Proteome: Novel Information on Teleost Fish B Cell Protein Repertoire and Identification of Potential B Cell Markers.

Authors:  Ma Michelle D Peñaranda; Ingvill Jensen; Linn G Tollersrud; Jack-Ansgar Bruun; Jorunn B Jørgensen
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

Review 7.  Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations.

Authors:  Carmen F Nobre; Matthew J Newman; Anne DeLisa; Pauline Newman
Journal:  Cancer Chemother Pharmacol       Date:  2019-05-27       Impact factor: 3.333

8.  Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.

Authors:  Ieva Bagdonaite; Hans H Wandall; Ivan V Litvinov; Claudia Nastasi; Jürgen C Becker; Sally Dabelsteen; Carsten Geisler; Charlotte M Bonefeld; Qian Zhang; Mariusz A Wasik; Youwen Zhou; Denis Sasseville; Niels Ødum; Anders Woetmann
Journal:  Oncotarget       Date:  2015-06-10

9.  A gammaherpesvirus Bcl-2 ortholog blocks B cell receptor-mediated apoptosis and promotes the survival of developing B cells in vivo.

Authors:  Carrie B Coleman; Jennifer E McGraw; Emily R Feldman; Alexa N Roth; Lisa R Keyes; Katrina R Grau; Stephanie L Cochran; Thomas J Waldschmidt; Chengyu Liang; J Craig Forrest; Scott A Tibbetts
Journal:  PLoS Pathog       Date:  2014-02-06       Impact factor: 6.823

Review 10.  Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells.

Authors:  Jhon R Enterina; Jaesoo Jung; Matthew S Macauley
Journal:  Biomed J       Date:  2019-09-16       Impact factor: 4.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.